The coming revolution in cervical cytology: A pathologist's guide for the clinician;Depistage du cancer du col, frottis selon Papanicolaou, analyse d'image en milieu liquide monocouche

References en Gynecologie Obstetrique

Volumn 5, Issue 2, 1997, Pages 169-175

  Weintraub, J ^a  

^a Laboratoire Weintraub   (Switzerland)

Author keywords

Cervical cancer screening; Image analysis; Liquid based; Monolayer; Pap smear

Indexed keywords

CANCER SCREENING; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EQUIPMENT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; REVIEW; TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 0031399932     PISSN: 12448168     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Anonymous. 1984. World Health Organization. Control of cancer of the cervix uteri. Bulletin of the World Health Organization; 65:607-618.
2. Devesa S.S., Young J, Brinton L. 1989. Recent trends in cervix uteri cancer. Cancer; 64: 2184-2190.
3. Laara E., Day N.E., Hakama M. 1984. Trends in mortality from cervical cancer in Nordic countries: association with organized screening programs. Lancet;1(8544):1247-1249.
4. Bogdanich W. 1987. Lax laboratories. the Pap test misses much cervical cancer through lab's errors. Wall Street Journal November 3, 1987:1. Physician's carelessness with Pap tests is cited in procedure's high failure rate. Wall Street Journal. December 29, 1987.17.
5. Bogdanich W. 1987. Lax laboratories. the Pap test misses much cervical cancer through lab's errors. Wall Street Journal November 3, 1987:1. Physician's carelessness with Pap tests is cited in procedure's high failure rate. Wall Street Journal. December 29, 1987.17.
6. Koss L.G. 1989. The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA;261:737-743.
7. Voelker R. 1996. Milwaukee deaths reignite critical issues in cervical cancer screening. JAMA; 273:1559-1560.
8. Mitchell H. 1997. Report disclaimers and informed expectations about the Papanicolaou smear: An Australian view. Arch Pathol Lab Med; 121: 327-330.
9. Linder J. 1997. Automation of the Papanicolaou smear. A technology assessmen perspective. Arch Pathol Lab Med;121:282-286.
10. Carmichael J.A., Jeffrey J.F., Steela H.D., Ohlke I.D. 1984. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol;48:685-690
11. Nasca P.C., Ellish N., Caputo T.A., Saboda K., Metzger B. 1991. An epidemiologic study of Pap screening histories in women with invasive carcinoms of the uterine cervix. NY State J Med ;91:152-156.
12. Jannerich D.D.T., Hadjimichael O., Schwartz P.E., Lowell D.M., Meigs JW, Merino MJ, et al. 1995. The screening histories of women with invasive cervical cancer. Am J Public Health; 85: 791-794.
13. Sherman M.E., Kelly D. 1992. High grade squamous intra-epithelial lesions and invasive carcinoma following the report of 3 negative Papanicolaou smears: screening failures or rapid progression ? Mod Pathol; 5:337-342.
14. Hatem F., Wilbur C. 1995. High grade cervical lesions following negative Papanicolaou smears: False-negative cervical cytology or rapid progression? Diagn Cytopathol;12:135-141.
15. Kurman R.J., Solomon D. 1994. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Springer Verlag, New York
16. Mitchell H., Medley G. 1992. Influence of endocervical status on the cytological prediction of cervical intra-epithelial neoplasia. Acta Cytol 36:875-880.
17. Boon M.E., Alons-van Kordelaar J.J.M., Riuetveld-Scheffers PEM. 1986. Consequences of the introduction of combined spatula and cytobrush sampling for cervical cytology. Improvements in smear quality and detection rates. Acta Cytol;30 264-270.
18. Anonymous. 1993. Cervical cytology: evaluation and management of abnormalities. Am Coll Gynecol Tech Bull 183.
19. Dey P., Collins S., Desai M., Woodman C. 1996. Adequacy of cervical cytology sampling with the Cervex brush and the Aylesbury spatula: a population based randomised controlled trial. Brit.J. Med.;313:721-723.
20. DeMay R. 1997 Common problems in Papanicolaou smear interpretation. Arch Pathol Lab Med;121:229-238.
21. Gay J.D., Donaldson L.D., Goellner J.R. 1985 False-negative results in cervical cytology studies. Acta Cytol;29:1043-1046.
22. Van dar Graaf Y., Vooijs G.P., Gaillard H.L.J., Go DMDS. 1987. Screening errors in cervical cytology screening. Acta Cytol; 31:434-438.
23. Morell N.D., Taylor J.R., Snyder R.N., Ziel H.K., Saltz A., Willie S. 1982. False-negative cytology rates in patients in whom invasive cervical carcinoma subsequently developed. Obstet Gynecol; 60:41.
24. Rubio C.A. 1977. The False-negative smear: II The trapping effect of collecting instruments. Obstet Gynecol; 49: 576-580.
25. Rubio C.A. 1977. The False negative smear: An instrumental error. Acta Cytol;21:500-501. (letter).
26. Hutchinson M.L., Isenstein L.M., Goodman A., Hurley A.A., Douglass K.L., Mui K.K., Patten F.W., Zahniser D.J.. 1994. Homogenous sampling accounts for the increased diagnostic accuracy using the ThinPrep processor. Am J Clin Pathol; 101:215-219.
27. Bosch M.M.C., Rietveld-Scheffers P.E.M., Boon M.E. 1992. Characteristics of false negative smears tested in the normal screening situation. Acta Cytol; 36:711-716.
28. Derman H. 1997. Quality and liability issues with the Papanicolaou smear. Lessons from the science of error prevention. Arch Pathol Lab Med;121:287-291.
29. Davay D.D., Nielsen M.L., Frable W.J., Rosenstock W., Lowell D.M., Kraemer B.B. 1993. Improving accuracy in gynecologic cytology: results of the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology (Pap). Arch Pathol Lab Med; 117: 1193-1198.
30. Naryshkin S. 1997. The False-negative fraction for Papanicolaou smears. Arch Pathol Lab Med; 121 :270-272.
31. Kamenstsky L.A., Gershman R.J., Kamentsky L.D., Pomeroy B.M., Weissman M.L. 1996. CompuCyte Corporation Pathfinder system: computerizing the microscope to improve cytology quality assurance. Acta Cytol;40:31-36
32. Grohs D.H., Gombrich P.P., Domanik R.A. 1996. AccuMed International Inc. Meeting the challenges in cervical cytology screening: the AccuCell series 2000 automated slide handling and data management system. Acta Cytol;40:26-30.
33. Vooijs G.P., Nauwelaers F.A., van Aspert.van Erp A.J.M. 1997. Cytosafe (+) a workstation for screening, supervision, reviewing, quality assurance and education in cytopathology. Acta Cytol;40:90-96.
34. Mango L. 1996. Neuromedical Systems Inc. Acta Cytol;40:53-59.
35. Denaro T.J., Herriman J.M., Shapira O. 1997. PAPNET testing system technical update. Acta Cytol;41 :65-73.
36. Patten S.F., Lee L.J.L., Nelson A.C. 1996. Neopath Inc. Neopath Autopap 300 automated pap screener system. Acta Cytol;40:45-52.
37. Colgan T.J., Patten S.F., Lee J.S.J. 1995. A clinical trial of the Autopap 300 QC system for quality control of cervico-vaginal cytology in the clinical laboratory. Acta Cytol;39:1191-1198.
38. Koss L., Lin E, Schreiber K. et al 1994. Evaluation of the Papnet ® cytology screening system for quality control of cervical smears. Am J Clin Pathol; 101:220-229.
39. Ouwerkerk-Noordam E., Boon M.E., Beck S. 1994 Computer assisted screening of cervical smears using the Papnet method, comparison with conventional screening and evaluation of the role of the cytologist. Cytopathology, 5:211-218.
40. Ashfaq R., Liang Y., Saboorian M.H. 1995. Evaluation of the Papnet ® for rescreening of negative cervical smears. Diagn Cytopathol; 13:31-36.
41. Sherman M.E., Mango L.J., Kelly D., Luding V., Pauli G., Copeland C., et al. 1994. II: Papnet review of smears preceding the diagnosis of high grade squamous intraepithelial lesions or carcinoma. Mod Pathol;7 578-581.
42. Doorneward H., van de Seijp H., Woudt J.M.C., van der Graaf Y., van den Tweel JG. 1997. Negative cervical smears before CIN3/carcinoma: Reevaluation with the PAPNET testing system. Acta Cytol;41 :74-78.
43. Hutchinson M.L. 1992. A new look at cervical cytology: ThinPrep multicenter trial results. Acta Cytol; 36:499-504.
44. Anonymous. 1994. Roche Image Analysis Systems in Compendium on the computerized cytology and histology laboratory. Editors. Wied GL, Bartels PH, Rosenthal DL, Schenck U, Tutorials of Cytology. Chicago Illinois. USA.
45. Lee K.R., Ashfaq R., Birdsong G.G., Corkhill M.E., Meintosh K.M., Inhorn SL. 1997. Comparison of conventional Papanicolaou smears and a fluid-based, thin layer system for cervical cancer screening. Obstet Gynecol 90:278-284.
46. Howell L.P., Davis R.L., Belk T.I., Agdigos R. 1997. Roche CytoRich preparations for gynecologic cytology. Mod Pathol;10:35a (abstract)
47. Laverty C.R., Farnsworth A., Thurloe J.K., Grieves A., Bowditch R. 1997. Evaluation of the CytoRich slide preparation process. Analyt Quant Cytol Histol;19:239-245.
48. Bishop J.W. 1997. Comparison of the CytoRich system with conventional cervical cytology. Preliminary data on 2,032 cases from a clinical trial site. Acta Cytol;41:15-23.
49. Wilbur DC, Facik MS, Rutkowski MA, Muiford DK, Atkison KM. 1997.Clinical trials of the CytoRich specimen-preparation device for cervical cytology. Preliminary results. Acta Cytol;47:24-29.
50. Linder J, Zahniser D. 1997. The ThinPrep Pap test: A Review of clinical studies. Acta Cytol,41 :30-39
51. Laverty C.R.A., Roberts J.M., Gurley A.M., Thurloe J.K., Bowditch R. 1997. Liquid based cytology - Comparison of ThinPrep 2000 with conventional Pap smears, presented at 3rd International Congress on Lower Genital Tract Infections and Neoplasia (Eurogin). Paris. April, 1997.
52. Hutchinson M.L., Schiffman M.H., Herrero R., Sherman M.E. 1995. Evaluation of conventional vs ThinPrep cervical smears in a population-based study of 10,000 women in Costa Rica. Acta Cytol 39: (abstract)
53. Wilbur D.C. 1994. ThinPrep Processor: Clinical trials demonstrates an increased detection rate of abnormal cervical cytologic specimens. Am J Clin path 1994; 101:209-214.
54. Corkill M., Knapp D., Martin J., Hutchinson M.L. 1997. Specimen adequacy of ThinPrep sample preparations in a direct-to-vial study. Acta Cytol;41:39-44.
55. Manos M.M., Hurley L.B., Kinney W.K., Sherman M.E., Kurman R.J., Hiatt RA. 1997. Utility of HPV testing and liquid based cytology in the triage of women with equivocal Pap smears. presented at 3rd International Congress on Lower Genital Tract Infections and Neoplasia (Eurogin). Paris. April, 1997.
56. Anonymous. 1997. ALTS: The ASCUS/LSIL. Triage Study. ALTS;1:1.